Jazz Pharmaceuticals (JAZZ) News Today $118.19 -1.86 (-1.55%) Closing price 04:00 PM EasternExtended Trading$118.98 +0.79 (+0.67%) As of 05:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Preview: Jazz Pharmaceuticals's EarningsMay 5 at 1:45 PM | benzinga.comEarnings To Watch: Jazz Pharmaceuticals (JAZZ) Reports Q1 Results TomorrowMay 5 at 1:45 PM | finance.yahoo.comAristotle Capital Management LLC Has $24.13 Million Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Aristotle Capital Management LLC cut its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 7.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 195,938 shares of the specialty pMay 5 at 7:01 AM | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Aequim Alternative Investments LPAequim Alternative Investments LP lessened its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 35.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 16,700 shares of the specialty pharmaceutical company's stocMay 5 at 6:13 AM | marketbeat.comAQR Arbitrage LLC Buys Shares of 41,818 Jazz Pharmaceuticals plc (NASDAQ:JAZZ)AQR Arbitrage LLC purchased a new position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 41,818 shares of the specialty pharmaceutical company's stock, valued at approximately $5,150,000. AQRMay 3 at 8:10 AM | marketbeat.comZacks Research Issues Optimistic Estimate for JAZZ EarningsJazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) - Investment analysts at Zacks Research lifted their Q1 2025 earnings estimates for Jazz Pharmaceuticals in a report released on Tuesday, April 29th. Zacks Research analyst S. Ganoria now expects that the specialty pharmaceutical company will pMay 3 at 6:49 AM | marketbeat.comAQR Capital Management LLC Trims Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)AQR Capital Management LLC decreased its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 3.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 533,682 shares of the specialty pharmaceutical company's stMay 3 at 5:52 AM | marketbeat.comThe Manufacturers Life Insurance Company Acquires 5,715 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)The Manufacturers Life Insurance Company raised its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 1.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 353,467 shares of the specialty pharmaceutical company's stock after purchaMay 3 at 5:43 AM | marketbeat.comQ1 EPS Estimate for Jazz Pharmaceuticals Raised by AnalystMay 3 at 1:29 AM | americanbankingnews.comZacks Research Issues Pessimistic Forecast for JAZZ EarningsJazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) - Zacks Research dropped their Q1 2026 earnings estimates for Jazz Pharmaceuticals in a research report issued to clients and investors on Tuesday, April 29th. Zacks Research analyst S. Ganoria now expects that the specialty pharmaceutical compMay 2 at 8:37 AM | marketbeat.comMML Investors Services LLC Purchases New Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)MML Investors Services LLC acquired a new position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 14,497 shares of the specialty pharmMay 2 at 4:15 AM | marketbeat.comJazz Pharmaceuticals (JAZZ) to Release Quarterly Earnings on TuesdayJazz Pharmaceuticals (NASDAQ:JAZZ) will be releasing its Q1 2025 earnings after the market closes on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-jazz-pharmaceuticals-plc-stock/)May 1, 2025 | marketbeat.com484,515 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Acquired by Darwin Global Management Ltd.Darwin Global Management Ltd. purchased a new stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 484,515 shares of the specialty pharMay 1, 2025 | marketbeat.comAdvisorShares Investments LLC Has $1.29 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)AdvisorShares Investments LLC raised its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 113.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,460 shares of the specialMay 1, 2025 | marketbeat.comZacks Research Issues Pessimistic Outlook for JAZZ EarningsMay 1, 2025 | americanbankingnews.comJazz Pharmaceuticals plc: Jazz Pharmaceuticals to Participate in the BofA Securities 2025 Healthcare ConferenceApril 30, 2025 | finanznachrichten.deJazz Pharmaceuticals to Participate in the BofA Securities 2025 Healthcare ConferenceApril 30, 2025 | prnewswire.comWith A 14% Return On Equity, Is Jazz Pharmaceuticals plc (NASDAQ:JAZZ) A Quality Stock?April 29, 2025 | uk.finance.yahoo.com161,812 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Bought by Tri Locum Partners LPTri Locum Partners LP purchased a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 161,812 shares of the specialty pharmaceutical company's stApril 29, 2025 | marketbeat.comSusquehanna Fundamental Investments LLC Takes Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Susquehanna Fundamental Investments LLC purchased a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 83,193 shares of the specialty pharApril 29, 2025 | marketbeat.com3 Reasons to Sell JAZZ and 1 Stock to Buy InsteadApril 28, 2025 | msn.comStifel Financial Corp Increases Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Stifel Financial Corp lifted its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 25.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 178,328 shares of the specialty pharmaceutical company's stApril 27, 2025 | marketbeat.comFirst Trust Advisors LP Cuts Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)First Trust Advisors LP lessened its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 4.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 321,215 shares of the specialty pharmaceutical company's stock after selling 15,812 shares during the quartApril 27, 2025 | marketbeat.comJazz Pharmaceuticals receives CHMP positive opinion for zanidatamabApril 26, 2025 | markets.businessinsider.comBarclays PLC Acquires 27,518 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Barclays PLC boosted its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 70.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 66,728 shares of the specialty pharmaceuticaApril 26, 2025 | marketbeat.comJazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract CancerApril 25, 2025 | prnewswire.comGMT Capital Corp Raises Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)GMT Capital Corp raised its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 140.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 508,800 shares of the specialty pharmaceutical company's stock afterApril 25, 2025 | marketbeat.comFuller & Thaler Asset Management Inc. Purchases 507,234 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Fuller & Thaler Asset Management Inc. raised its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 117.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor ownedApril 25, 2025 | marketbeat.com9,302 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Acquired by J. Safra Sarasin Holding AGJ. Safra Sarasin Holding AG purchased a new stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 9,302 shares of the specialty pharmaceutical company's stock, valued at appApril 25, 2025 | marketbeat.comMarshall Wace LLP Invests $7.31 Million in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Marshall Wace LLP purchased a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 59,381 shares of the specialty pharmaceutical company's stoApril 25, 2025 | marketbeat.comDiadema Partners LP Takes $1.81 Million Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Diadema Partners LP purchased a new position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 14,719 shares of the specialty pharmaceutical companApril 24, 2025 | marketbeat.comDimensional Fund Advisors LP Has $250.62 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Dimensional Fund Advisors LP lifted its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 18.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,035,070 shares ofApril 24, 2025 | marketbeat.comJazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse GliomaApril 23, 2025 | prnewswire.comJazz Pharmaceuticals plc: Jazz Pharmaceuticals Completes Acquisition of ChimerixApril 23, 2025 | finanznachrichten.deCapital World Investors Buys 104,195 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Capital World Investors lifted its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 5.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,923,342 shares of the specialty pharmaceutical company's stock after acquirinApril 23, 2025 | marketbeat.comMariner LLC Acquires 6,782 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Mariner LLC increased its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 33.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 26,803 shares of the specialty pharmaceutical company's stock after purchasing an additiApril 23, 2025 | marketbeat.comJazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025April 22, 2025 | prnewswire.comCanada Pension Plan Investment Board Purchases 8,000 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Canada Pension Plan Investment Board increased its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 4.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 189,000 shares of the specialty pharmaceApril 22, 2025 | marketbeat.comGuggenheim Capital LLC Has $3.05 Million Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Guggenheim Capital LLC lessened its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 30.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 24,751 shares of the specialty pharmaceutical coApril 22, 2025 | marketbeat.comJazz Pharmaceuticals Completes Acquisition of ChimerixApril 21, 2025 | prnewswire.comInvesco Ltd. Sells 55,493 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Invesco Ltd. lessened its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 21.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 205,480 shares of the specialty pharmaceutical company's stock after selling 55,493 shares during tApril 21, 2025 | marketbeat.comEnvestnet Asset Management Inc. Has $11.18 Million Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Envestnet Asset Management Inc. increased its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 36.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 90,742 shares of the specialty pharmaceutical company's stock after purchasing an adApril 20, 2025 | marketbeat.comDean Investment Associates LLC Boosts Stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Dean Investment Associates LLC boosted its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 15.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 28,451 shares of the specialtApril 19, 2025 | marketbeat.comBridgewater Associates LP Boosts Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Bridgewater Associates LP grew its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 69.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 192,035 shares of the specApril 18, 2025 | marketbeat.comOntario Teachers Pension Plan Board Boosts Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Ontario Teachers Pension Plan Board lifted its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 79.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,741 shares of the sApril 18, 2025 | marketbeat.comFmr LLC Has $91.42 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Fmr LLC cut its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 11.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 742,305 shares of the specialty pharmaceuticalApril 18, 2025 | marketbeat.comPharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs PeersApril 17, 2025 | finance.yahoo.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Wells Fargo & Company MNWells Fargo & Company MN lessened its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 17.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 96,952 shares of the specialty pharmaceutical company's stock aftApril 17, 2025 | marketbeat.comRockefeller Capital Management L.P. Buys 4,006 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Rockefeller Capital Management L.P. boosted its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 1.6% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 250,410 shares of the speApril 16, 2025 | marketbeat.comLegal & General Group Plc Has $15.86 Million Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Legal & General Group Plc lessened its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 12.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 128,774 shares of the specialty pharmaceutical company's stock after sellingApril 16, 2025 | marketbeat.com Get Jazz Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Email Address JAZZ Media Mentions By Week JAZZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JAZZ News Sentiment▼0.730.72▲Average Medical News Sentiment JAZZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JAZZ Articles This Week▼2711▲JAZZ Articles Average Week Get Jazz Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RPRX News CORT News PRGO News SUPN News PCRX News OMER News NKTR News ASMB News CPIX News LLY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:JAZZ) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jazz Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Jazz Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy JAZZ Stock Free JAZZ Stock Alerts